UroGen Pharma Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 11/14/2025 | 4.54 M | $90.65 M | 0.00% | 9.52% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2025 | 4.22 M | $84.11 M | 100.00% | 8.83% |
| TORONTO DOMINION BANK | 11/14/2025 | 3.19 M | $63.65 M | 0.00% | 6.68% |
| BLACKROCK, INC. | 11/12/2025 | 2.58 M | $51.50 M | 7.32% | 5.41% |
| MORGAN STANLEY | 11/14/2025 | 2.53 M | $50.44 M | 2.02% | 5.30% |
| JEFFERIES FINANCIAL GROUP INC. | 11/13/2025 | 2.20 M | $43.88 M | 0.00% | 4.61% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.58 M | $31.47 M | -22.01% | 3.30% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.47 M | $29.30 M | 147.25% | 3.08% |
| ACORN CAPITAL ADVISORS, LLC | 11/17/2025 | 1.26 M | $25.13 M | 0.00% | 2.64% |
| SG AMERICAS SECURITIES, LLC | 10/23/2025 | 1.16 M | $23.09 M | 0.72% | 2.42% |
| MENORA MIVTACHIM HOLDINGS LTD. | 11/13/2025 | 1.15 M | $22.99 M | 0.00% | 2.41% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.00 M | $19.95 M | 0.00% | 2.09% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 1.00 M | $19.95 M | 1,900.00% | 2.09% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 888.93 K | $17.73 M | 3,140.50% | 1.86% |
| STATE STREET CORP | 11/14/2025 | 819.45 K | $16.35 M | 1.46% | 1.72% |
| MIGDAL INSURANCE & FINANCIAL HOLDINGS LTD. | 10/30/2025 | 770.91 K | $15.38 M | 0.00% | 1.61% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/17/2025 | 717.35 K | $14.31 M | 100.00% | 1.50% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 689.00 K | $13.75 M | 44.02% | 1.44% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 687.48 K | $13.72 M | 100.00% | 1.44% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 679.00 K | $13.55 M | -68.92% | 1.42% |
| CITADEL ADVISORS LLC | 11/14/2025 | 602.28 K | $12.02 M | 10.88% | 1.26% |
| BOXER CAPITAL MANAGEMENT, LLC | 11/14/2025 | 575.00 K | $11.47 M | 0.00% | 1.20% |
| JPMORGAN CHASE & CO | 11/26/2025 | 534.55 K | $10.66 M | 36.94% | 1.12% |
| NUVEEN, LLC | 11/12/2025 | 507.53 K | $10.13 M | 510.41% | 1.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 471.23 K | $9.40 M | 0.11% | 0.99% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 424.92 K | $8.48 M | 46.23% | 0.89% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 402.60 K | $8.03 M | 127.84% | 0.84% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 386.20 K | $7.70 M | 103.90% | 0.81% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 369.70 K | $7.38 M | -23.98% | 0.77% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 356.62 K | $7.12 M | -1.34% | 0.75% |
| JANE STREET GROUP, LLC | 11/14/2025 | 328.42 K | $6.55 M | 122.99% | 0.69% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 308.33 K | $6.15 M | 328.70% | 0.65% |
| WOODLINE PARTNERS LP | 11/14/2025 | 306.37 K | $6.11 M | -0.12% | 0.64% |
| VANGUARD GROUP INC | 11/07/2025 | 303.79 K | $6.06 M | 19.14% | 0.64% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 297.85 K | $5.94 M | 36.32% | 0.62% |
| ATOM INVESTORS LP | 11/14/2025 | 291.96 K | $5.82 M | -8.07% | 0.61% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2025 | 282.41 K | $6.94 M | -56.99% | 0.59% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 275.10 K | $5.49 M | 620.16% | 0.58% |
| NORTHERN TRUST CORP | 11/14/2025 | 261.40 K | $5.21 M | -2.36% | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/16/2025 | 259.14 K | $5.17 M | -9.98% | 0.54% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 204.19 K | $4.07 M | -11.82% | 0.43% |
| PRIVIUM FUND MANAGEMENT B.V. | 11/04/2025 | 196.62 K | $3.92 M | 82.70% | 0.41% |
| WALLEYE CAPITAL LLC | 11/14/2025 | 190.45 K | $3.80 M | -44.98% | 0.40% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2025 | 184.38 K | $3.68 M | -29.57% | 0.39% |
| UBS GROUP AG | 11/13/2025 | 180.46 K | $3.60 M | -41.51% | 0.38% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 171.20 K | $3.42 M | -46.01% | 0.36% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 162.26 K | $3.24 M | 559.38% | 0.34% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 147.23 K | $2.94 M | -69.63% | 0.31% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 135.00 K | $2.69 M | 100.00% | 0.28% |
| HRT FINANCIAL LP | 11/14/2025 | 133.67 K | $2.67 M | 28.25% | 0.28% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
UroGen Pharma Ltd. institutional Ownership - FAQ's
During the previous two years, 198 institutional investors and hedge funds held shares of UroGen Pharma Ltd.. The most heavily invested institutionals were:
RTW INVESTMENTS, LP: 4.54 M
Paradigm Biocapital Advisors LP: 4.22 M
TORONTO DOMINION BANK: 3.19 M
BlackRock, Inc.: 2.58 M
MORGAN STANLEY: 2.53 M
Jefferies Financial Group Inc.: 2.2 M
92.11% of UroGen Pharma Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 51.49 M shares in the last 24 months. This purchase volume represents approximately $895.85 M in transactions.